Axsome Therapeutics, Inc. · XETR:19X
Axsome Therapeutics, Inc. shareholders
As of Sep 30, 2026, 454 institutions reported holding Axsome Therapeutics, Inc., 76.2% of its shares. Largest: Vanguard, BlackRock and Invesco. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Axsome Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 4.34M | 8.3% | +45,307 | Nov 16, 2026 |
| BlackRock | 3.45M | 6.6% | +348K | Nov 13, 2026 |
| Invesco | 1.93M | 3.7% | +259K | Nov 12, 2026 |
| Fidelity | 1.44M | 2.7% | −94,724 | Nov 10, 2026 |
| Millennium | 1.32M | 2.5% | +767K | Nov 16, 2026 |
| Two Sigma | 1.11M | 2.1% | +441K | Nov 16, 2026 |
| Franklin Templeton | 1.03M | 2.0% | +120K | Nov 12, 2026 |
| Geode Capital | 1.01M | 1.9% | +43,201 | Nov 6, 2026 |
| UBS | 1.01M | 1.9% | +727K | Nov 16, 2026 |
| State Street | 823K | 1.6% | +37,669 | Nov 12, 2026 |